Frank J. Godinho - Concepedia

Concepedia

Author

Frank J. Godinho

Dana-Farber Cancer Institute ORCID

Also Known As

F Godinho, F. Godinho, FLÁVIO PEREIRA GODINHO, Frank Godinho, Frank J Godinho, Frank J. Godinho, Sorensen, Poul H.

21

Publications

1.1K

Citations

7

H-Index

24

Concepts

All Affiliations

Dana-Farber Cancer Institute Boston Children's Hospital Harvard University Howard Hughes Medical Institute Brigham and Women's Hospital

FJ

About

Frank J. Godinho is an author at Dana-Farber Cancer Institute specializing in medicine, cell biology, and gene expression.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	704
2	Cell Biology	3	3	588
3	Natural Sciences	1	1	305
4	Pharmacology	1	1	116
5	Cancer Cell Biology	1	1	141

Frank J. Godinho

×

7

Publications

1.1K

Citations

7

H-Index

	Year	Citations
Developmental stage–selective effect of somatically mutated leukemogenic transcription factor GATA1 Zhe Li, Frank J. Godinho, Jan‐Henning Klusmann, Nature Genetics Developmental Stage–selective EffectTranscriptional RegulationDevelopmental BiologySomatic VariantMedicine	2005	305
miR-125b-2 is a potential oncomiR on human chromosome 21 in megakaryoblastic leukemia Jan‐Henning Klusmann, Zhe Li, Katarina Böhmer, Genes & Development	2010	218
ETV1 directs androgen metabolism and confers aggressive prostate cancer in targeted mice and patients Esther Baena, Zhen Shao, Douglas E. Linn, Genes & Development	2013	186
Developmental stage-specific interplay of GATA1 and IGF signaling in fetal megakaryopoiesis and leukemogenesis Jan‐Henning Klusmann, Frank J. Godinho, Kirsten Heitmann, Genes & Development Systems BiologyDevelopmental BiologyDevelopmental Stage-specific InterplayAdult LeukemiasOncogenic Agent	2010	142
ETV6-NTRK3 Fusion Oncogene Initiates Breast Cancer from Committed Mammary Progenitors via Activation of AP1 Complex Zhe Li, Cristina E. Tognon, Frank J. Godinho, Cancer Cell Cell RegulationAp1 ComplexMedicineCancer Cell BiologyCommitted Mammary Progenitors	2007	141
A comparison of two doses of adriamycin in the primary chemotherapy of disseminated breast carcinoma J. Carmo-Pereira, FO Costa, E Henriques, British Journal of Cancer Breast OncologyMedicinePharmacologyBreast CancerPharmacotherapy	1987	116
Reduced <i>Erg</i> Dosage Impairs Survival of Hematopoietic Stem and Progenitor Cells Ying Xie, Mia Lee Koch, Xin Zhang, Stem Cells	2017	21

Page 1